Healthcare -
Biotechnology - NASDAQ - US
$ 1.2
3.45 %
$ 49.3 M
Market Cap
-4.14
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
58.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Anebulo Pharmaceuticals, Inc.
ANEB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ANEB
EBIT FORECAST
EBIT Forecast Chart ANEB
NET INCOME FORECAST
Net Income Chart ANEB